InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Stamoulis Christiana, Chief Financial Officer. Director active across 2 companies, notably INCYTE CORP. Aggregated, 8 disclosures have been recorded. The latest transaction was filed on 11 February 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is free.
Declarations8 total
1,565 shares
Common Stock
SEC:0001127602-22-009145:0·
€49,476846 shares@ €58.48180.0003% mcap100.0% of flow
Common Stock
SEC:0001209191-22-009777:0·
014,463 shares0
Common Stock
SEC:0001209191-22-001661·
014,463 shares0
Common Stock
SEC:0001209191-22-001661:0·
0379 shares0
Common Stock
SEC:0001209191-21-066421·
0379 shares0
Common Stock
SEC:0001209191-21-066421:0·
07,853 shares0
Common Stock
SEC:0001209191-21-045822·
07,853 shares0
Common Stock
SEC:0001209191-21-045822:0·
8 of 8 declarations
About Stamoulis Christiana
Stamoulis Christiana serves as Executive VP and Chief Financial Officer at Incyte Corp and Hologic Inc. She is responsible for the financial management of both companies, including financial planning and risk management. Christiana plays a key role in developing financial strategies and communicating financial results to shareholders. Her expertise in finance is essential for the growth and sustainability of the companies.
